Healthcare Sales & Marketing Network News: Huntington

Searching News Database: Huntington

HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 10 May 2021
Medtronic Launches New Pediatric Monitor That Alerts Clinicians to Potential Airway Obstructions During Ventilation
Devices Monitoring Product Launch

HSMN NewsFeed - 29 Jul 2020
Biotech Vico Therapeutics raises $31 million (�27 million) in Series A financing round to advance therapies for rare central nervous system diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces Clinical Trial Results of REVERSE-SD, a Phase 2b Study of Neflamapimod in Early-stage Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Apr 2019
EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 11 Mar 2019
Alcyone Lifesciences Receives Breakthrough Device Designation from U.S. FDA for the ThecaFlex DRx(TM) System
Devices Neurology Oncology Drug Delivery FDA

HSMN NewsFeed - 3 Oct 2018
Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 23 Jun 2017
EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for the First-Line Treatment of Advanced Renal Cell Carcinoma in Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 7 Jun 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Apr 2017
Neurocrine Announces INGREZZA(TM) Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington�s Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Mar 2017
Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2017
Sangamo Therapeutics Announces Chief Financial Officer Succession
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 30 Nov 2016
Neurocrine Announces FDA Advisory Committee Meeting to Review INGREZZA(TM) (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 11 Oct 2016
Neurocrine Announces INGREZZA(TM) (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia has been Accepted for Priority Review by U.S. FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 4 Oct 2016
EUSA Pharma Acquires Global Rights to Neuroblastoma Treatment Isqette(R) (Dinutuximab Beta) from Apeiron Biologics
Biopharmaceuticals Oncology Acqusitions

HSMN NewsFeed - 26 Jul 2016
Zimmer Biomet Unveils Signature Solutions(TM)
Devices Orthopaedic Product Launch

HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Jun 2016
Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR(TM) at the 39th European Cystic Fibrosis Conference
Biopharmaceuticals

HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2016
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Jan 2016
Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Dec 2015
VistaGen Secures Exclusive Worldwide Commercial Rights to Three Proprietary Stem Cell Technologies from University Health Network
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Aug 2015
WAVE Life Sciences Raises $66 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Aug 2015
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 22 Jul 2015
Voyager Therapeutics Appoints Michael Higgins to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 15 Jul 2015
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2015
Omidria(R) Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 23 Mar 2015
EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals
Biopharmaceuticals Acquisitions Product Launch

HSMN NewsFeed - 30 Oct 2014
Omidria(TM) Granted Pass-Through Reimbursement Status from CMS
Biopharmaceuticals Ophthalmology Reimbursement

HSMN NewsFeed - 23 Oct 2014
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jun 2014
Varian Medical Systems to Equip Prime Healthcare Services Hospitals with Varian Technology for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology

HSMN NewsFeed - 2 Jun 2014
Omeros Receives FDA Approval of Omidria(TM) for Use in Cataract and Other Intraocular Lens Replacement Procedures
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals

HSMN NewsFeed - 21 Nov 2013
Otsuka and Lundbeck's Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Oct 2013
Auspex Appoints Pratik Shah as CEO and Expands Executive Team
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Oct 2013
Omeros Hires Michael K. Inouye to Lead Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 26 Aug 2013
Sangamo BioSciences to Acquire Ceregene
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 6 Aug 2013
Medtronic Introduces the First and Only Neurostimulation Systems for Chronic Pain Designed for Full-Body MRI Safety*
Devices Neurology Product Launch

HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Mar 2013
Symmetry Surgical Unveils Next Generation Bookwalter(R) Self-Retaining Rotilt Ratchet
Devices Surgery

HSMN NewsFeed - 27 Feb 2013
Symmetry Surgical Continues European Presence With Distributor in the United Kingdom
Devices Surgery Distribution

HSMN NewsFeed - 8 Jan 2013
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 8 Nov 2012
Auspex Pharmaceuticals Closes $25 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 16 Oct 2012
Symmetry Surgical Continues Global Expansion Through New Distributor Partnership With AMT Electrosurgery Inc. in Canada
Devices Surgery Distribution

HSMN NewsFeed - 10 Sep 2012
Raptor Pharmaceutical Corp. Expands Senior Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2012
Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 28 Aug 2012
Symmetry Medical Announces FDA Clearance of Its FLASH PAK(R) Evolution Valve
Devices FDA

HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2012
Symmetry Medical Launches Complementary Additions to Its Micro Instrument Portfolio
Devices Neurosurgery

HSMN NewsFeed - 28 Mar 2012
Raptor Pharmaceutical Corp. Announces the Appointment of Henk Doude van Troostwijk as General Manager of European Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2011
Interleukin Genetics Appoints Lynn Doucette-Stamm Vice President of Development
Diagnostics Personnel

HSMN NewsFeed - 12 Dec 2011
Symmetry Medical to Acquire the Surgical Instruments Business of Codman & Shurtleff
Devices Acquisitions

HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Regenerative Medicine Neurology

HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 29 Jun 2011
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Jun 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology

HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Appoints Kathlene L. Powell Vice President, Quality Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2011
Pfizer and Medivation Announce Results From Phase 3 Horizon Trial of Dimebon in Huntington Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 31 Mar 2011
iTech Medical Appoints Warren G. Baker as Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 22 Feb 2011
iTech Medical Appoints Warren G. Baker as President, COO and Director
Devices Personnel

HSMN NewsFeed - 10 Feb 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology

HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA

HSMN NewsFeed - 10 Jan 2011
Raptor Pharmaceutical Hires Patrick Reichenberger to Lead Commercial Development of DR Cysteamine for Nephropathic Cystinosis
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2010
Cortex Obtains Exclusive Worldwide Rights for the Combination of AMPAKINE(R) and mGluR5 Compounds for the Treatment of Fragile X
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Regenerative Medicine

HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Jun 2010
Ipsen: Encouraging results of GuidAge(R), large scale European trial conducted in the prevention of Alzheimer's Dementia
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 11 May 2010
BrainStorm Announces Significant Milestones Achieved and 2009 Review
Regenerative Medicine Neurology

HSMN NewsFeed - 29 Mar 2010
Medivation Announces Reduction in Workforce
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Mar 2010
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Jan 2010
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
Regenerative Medicine Neurology

HSMN NewsFeed - 13 Jan 2010
FDA Gives TCA Cellular Therapy Green Light to Proceed with First ALS Adult Stem Cell Trial Using Patient's Own Stem Cells
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2009
FDA Broadens Clearance for Agendia's MammaPrint(R)
Diagnostics Oncology FDA

HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 6 Nov 2009
Amarin Appoints John F. Thero as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2009
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Sep 2009
Agendia Raises US $23 Million in Series E Financing
Diagnostics Venture Capital

HSMN NewsFeed - 21 Sep 2009
Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 24 Aug 2009
BrainStorm Cell Therapeutics Secures Funding to Reach Clinical Trials for ALS
Regenerative Medicine Neurology

HSMN NewsFeed - 30 Jul 2009
Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2009
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Jul 2009
Stem Cell Therapeutics Corp. Receives Green Light to Begin Enrolling Patients in the India Phase IIb Acute Ischemic Stroke Trial
Regenerative Medicine Neurology

HSMN NewsFeed - 6 Jul 2009
Huntington Memorial Hospital is First in Southern California to Install Toshiba's Aquilion ONE Dynamic Volume CT System
Devices Radiology

HSMN NewsFeed - 18 May 2009
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 11 May 2009
Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
Devices Cardiology

HSMN NewsFeed - 15 Apr 2009
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 13 Apr 2009
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals

HSMN NewsFeed - 18 Mar 2009
Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2009
Neuralstem's ALS Trial on Clinical Hold
Regenerative Medicine Neurology

HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Diagnostics Oncology

HSMN NewsFeed - 21 Jan 2009
Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2)
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2009
Alnylam Provides Update on Kreutzer-Limmer Patent Family
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2009
Agendia Appoints New Chief Financial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 8 Dec 2008
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
Biopharmaceuticals Reimbursement Distribution

HSMN NewsFeed - 2 Dec 2008
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Biopharmaceuticals

HSMN NewsFeed - 1 Dec 2008
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
Biopharmaceuticals Neurology

HSMN NewsFeed - 10 Nov 2008
Targeted Genetics Board of Directors Names B.G. Susan Robinson as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2008
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Oct 2008
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2008
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Sep 2008
FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Sep 2008
Amarin Appoints Dr. Paresh Soni as SVP and Head of Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 Sep 2008
Agendia Launches TargetPrint(R) for Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 3 Sep 2008
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2008
World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
Regenerative Medicine Personnel

HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Aug 2008
Cambridge Laboratories Announces FDA Approval of XENAZINE(R) (tetrabenazine) in the US
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 15 Aug 2008
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 4 Aug 2008
Regulus Therapeutics Appoints Garry Menzel, Ph.D., as Executive Vice President Corporate Development and Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2008
Medivisor Inc. Announces New Sales and Marketing Agreement for Mucotrol(TM) With Cura Pharmaceutical Co Inc.
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 14 Jul 2008
New Publication Shows Cleviprex(TM) is Effective for Rapid Treatment of Acute Hypertension After Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Jul 2008
Neurobiological Technologies' CEO to Retire on December 31, 2008
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 9 Jun 2008
Curlin Medical Awarded Three-Year Pain Management - Local Anesthetic Contract by Premier, Inc.
Devices Drug Delivery Group Purchasing

HSMN NewsFeed - 9 Jun 2008
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 13 May 2008
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Devices Cardiology

HSMN NewsFeed - 12 May 2008
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 May 2008
Hospitals, Healthcare Systems to Save with Premier New Pain Management, Local Anesthetic Agreements
Devices Group Purchasing

HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 25 Mar 2008
Medivation Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2008
North Shore Radiation Therapy Opens on Long Island, Offers Cancer Patients Access to New, Advanced Cancer Treatments
Devices Oncology

HSMN NewsFeed - 11 Mar 2008
Pipex Pharmaceuticals Announces Cost Reduction Measures
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Mar 2008
Cortex Receives Approval from German Regulatory Authority to Proceed with Two Clinical Trials for AMPAKINE(R) CX717 for the Acute Treatment of Respiratory Depression Due to Opiate Analgesics
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Feb 2008
Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Feb 2008
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2008
Misonix Announces Distribution Agreement for New BoneScalpel(TM) Medical Device
Devices Distribution

HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Jan 2008
Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Jan 2008
Medivation Names Rohan Palekar Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 19 Nov 2007
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Nov 2007
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
Regenerative Medicine Neurology

HSMN NewsFeed - 31 Oct 2007
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2007
Rami Efrati, Former VP Business Development and Marketing for NICE SYSTEMS' Government Division, Joins BrainStorm As CEO
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Oct 2007
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
Regenerative Medicine Neurology

HSMN NewsFeed - 26 Sep 2007
EnVivo Pharmaceuticals Announces Executive Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 10 Sep 2007
BrainStorm Cell Therapeutics Takes Initial Steps Toward FDA Submission
Regenerative Medicine Neurology

HSMN NewsFeed - 30 Aug 2007
Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2007
Prestwick Pharmaceuticals, Inc. Strengthens Management Team with Appointment of Robert S. Radie as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Aug 2007
MethylGene and Pharmion Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Aug 2007
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Aug 2007
Medivation Names Robert Elfont, M.D., Ph.D., Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jul 2007
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
Biopharmaceuticals Devices Drug Delivery Neurology

HSMN NewsFeed - 16 Jul 2007
BrainStorm Cell Therapeutics Elects Moshe Lion to Its Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 28 Jun 2007
Avicena to Advance Huntington's Disease Clinical Program into Phase III
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Jun 2007
Medivation's Dimebon(TM) Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Jun 2007
Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 May 2007
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 May 2007
Celladon and Targeted Genetics Initiate Phase I Clinical Trial of MYDICAR(TM) in Patients With Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 24 Apr 2007
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 10 Apr 2007
Amarin Appoints Declan Doogan to New Position of President-Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2007
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2007
Huntington Hospital Cardiologist Available to Comment on Courage Study
Devices Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 22 Mar 2007
Avicena Announces Patient Enrollment in National Institutes of Health (NIH) Phase III Parkinson's Disease Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Mar 2007
Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Mar 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2007
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
Biopharmaceuticals Drug Delivery Neurology Licensing

HSMN NewsFeed - 27 Feb 2007
Targeted Genetics Responds to Litigation Release SEC V. Crestview Capital Partners, LLC and Stewart R. Flink
Biopharmaceuticals Litigation

HSMN NewsFeed - 27 Feb 2007
Amarin Appoints Professor William Hall as Non-Executive Director
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Feb 2007
Targeted Genetics Provides Inflammatory Arthritis Clinical Trial Update
Biopharmaceuticals

HSMN NewsFeed - 8 Feb 2007
Polyanalgesic Consensus Panel Issues New Guidelines for Pain Management via Intraspinal Infusion
Biopharmaceuticals

HSMN NewsFeed - 5 Feb 2007
Amarin Announces Completion of Two Phase III Trials With Miraxion in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Jan 2007
PsychoGenics Announces the Launch of Psylin Neurosciences, Inc. in Partnership with Amylin Pharmaceuticals
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
Medivation Names Lisa Taylor Vice President of Commercial Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
Nektar Appoints Howard W. Robin President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Dec 2006
Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Dec 2006
PsychoGenics Announces Drug Discovery and Development Agreement With Eli Lilly and Company
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Dec 2006
Merck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of Sirna by Merck
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Dec 2006
Avicena Signs Agreement with the National Institute of Neurological Disorders and Stroke for Phase III Trial for Novel Parkinson's Disease Candidate
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Nov 2006
Medipattern to Customize a Version of B-Cad'TM' for Sonocine, Inc.
Devices Radiology

HSMN NewsFeed - 30 Oct 2006
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 3 Oct 2006
B. Braun Awarded Major Home Infusion Pump Contract by Coram Specialty Infusion Services
Devices

HSMN NewsFeed - 2 Oct 2006
Edison Pharma and Institute of Vision Enter Into Collaboration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 28 Sep 2006
Medivation Receives FDA Permission to Begin Dimebon Huntington's Disease Trial
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 21 Sep 2006
Medivation's Dimebon Meets All Five Efficacy Endpoints in Phase 2 Alzheimer's Disease Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Sep 2006
Medivation Appoints Dr. Andrew A. Protter Vice President of Preclinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Aug 2006
Prestwick Pharmaceuticals Appoints George F. Horner III as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jul 2006
Amarin Completes Target Patient Enrollment in European Phase III Trial of Miraxion(TM) in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Jun 2006
Amarin Completes Target Patient Enrollment in North American Phase III Trial of Miraxion(TM) in Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 22 Jun 2006
Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the European Rheumatology Meeting
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2006
Second Generation Cervical Artificial Disc Kicks Off Multiple U.S. Surgeries in Research Study Launch
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 30 May 2006
FoldRx Pharmaceuticals Closes $43 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 May 2006
Amarin Acquires Parkinson's Disease Drug Candidate
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 11 May 2006
Stem Cell Therapeutics Corp. Announces Issuance of Second US Patent
Regenerative Medicine

HSMN NewsFeed - 10 May 2006
Medivation Provides Update on Huntington's Disease IND
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 May 2006
Avicena Announces Phase III ALS Trial Results
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 May 2006
Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKline
Biopharmaceuticals

HSMN NewsFeed - 26 Apr 2006
Zambia Begins First Preventive HIV Vaccine Trial
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 11 Apr 2006
Moog Announces Acquisition Closing
Devices Mergers & Acquisitions

HSMN NewsFeed - 3 Apr 2006
GlaxoSmithKline and Sirna Therapeutics Announce Major Alliance in RNAi-Based Therapeutics for Respiratory Disease
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2006
Prestwick Pharmaceuticals Receives FDA Approvable Letter for XENAZINE(R) (Tetrabenazine) for Treatment of Chorea Associated with Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Mar 2006
Avicena Compound Receives Orphan Drug Designation for Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 14 Mar 2006
Avicena Announces Promising Phase II Results From Parkinson's Disease Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Mar 2006
Medivation Receives FDA Comments on Huntington's Disease IND
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Feb 2006
Medivation Exceeds Patient Enrollment Target in Phase 2 Alzheimer's Disease Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Feb 2006
Study Published in Neurology Shows Tetrabenazine Significantly Improves Debilitating Movement Disorder Caused by Huntington's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Feb 2006
Sirna Therapeutics Appoints Gregory Weaver as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jan 2006
Stem Cell Therapeutics Corp. Announces Selected Upcoming Development Milestones
Biopharmaceuticals Regenerative Medicine Neurology

HSMN NewsFeed - 18 Jan 2006
Targeted Genetics Appoints David J. Poston as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2006
MultiCell Technologies In-Licenses Phase IIb/III Drug for the Treatment of Fatigue in Multiple Sclerosis from Amarin Corporation
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 3 Jan 2006
Amarin Licenses Phase IIb/III Drug for the Treatment of Fatigue in Multiple Sclerosis to Multicell Inc.
Biopharmaceuticals Neurology Licensing

Return to NewsFeed

Additional items found! 56

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 56 additional stories matching:
Huntington
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.